Cancer remained the leading cause of death in Taiwan in 2025 [1].
This trend persists despite a general decline in overall mortality rates across the population. The continued dominance of cancer as a primary killer signals a need for systemic shifts in how the region approaches long-term oncology care and preventative screening.
Data indicates that cancer has held the top position on the list of leading causes of death for decades [1]. While the total number of deaths may be falling, the specific mortality rates for several types of cancer continue to rise [1]. This discrepancy suggests that while general healthcare may be improving, specific oncological challenges are becoming more acute.
In response to these findings, the Taiwanese government plans to expand its efforts regarding cancer detection and treatment [1]. The strategy focuses on increasing the accessibility of screenings to identify malignancies at earlier, more treatable stages. Officials said they aim to curb the rising death rates of specific cancer types through more aggressive intervention and updated medical protocols [1].
Public health officials said early detection is important to shift the mortality trend. By broadening the scope of available tests, the government hopes to reduce the number of late-stage diagnoses that contribute to the high death toll [1]. These measures are intended to counter the rise in specific cancer deaths that have offset other health gains in the region [1].
“Cancer remained the leading cause of death in Taiwan in 2025”
The persistence of cancer as the primary cause of death in Taiwan, even as general mortality drops, suggests a demographic or environmental shift that is outpacing current medical interventions. The government's pivot toward expanded detection indicates a transition from general healthcare maintenance to a targeted war on specific high-mortality malignancies to prevent further increases in cancer-related deaths.
